Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in…
Los Angeles, California--(Newsfile Corp. - September 2, 2025) - Each year, more than 15,000 families in the U.S. hear the…
BOSTON, Sept. 2, 2025 /PRNewswire/ -- TOBY, Inc., a leader in noninvasive multi-cancer early detections, has appointed Matthew Collier to the TOBY…
VISERA™ S Offers Advanced Diagnostic Imaging Capabilities in a Variety of Patient Settings CENTER VALLEY, Pa., Sept. 2, 2025 /PRNewswire/…
BOZEMAN, Mont., Sept. 2, 2025 /PRNewswire/ -- Golden Helix, a global leader in clinical bioinformatics, today announced a strategic partnership with…
SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans…
Pipeline of Disease-Modifying Therapies Targets Hypoparathyroidism, Pancreatic Cancer, osteoporotic fractures, and Crohn's Disease NES ZIONA, Israel, Sept. 2, 2025 /PRNewswire/ -- Amorphical,…
HARTFORD, Conn. & PITTSBURGH--(BUSINESS WIRE)--Abridge’s AI-powered ambient clinical intelligence platform has been selected by Hartford HealthCare, Connecticut’s most comprehensive healthcare…
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, today announced the submission of…
Grand Cayman, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology…